Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cytogenetic abnormalities in multiple myeloma.

R Fonseca1, L J Coignet, G W Dewald

  • 1Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA. fonseca.rafael@mayo.edu

Hematology/Oncology Clinics of North America
|January 8, 2000
PubMed
Summary

Chromosomal abnormalities are key in multiple myeloma development and predicting patient outcomes. Future evaluations of myeloma patients will integrate cytogenetic composition analysis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peripheral blood cfDNA detection using clonoSEQ assay in multiple myeloma is concordant with bone marrow and clinical biomarkers.

Blood cancer journal·2026
Same author

Author Correction: ROBIN: Reference observatory of basins for international hydrological climate change detection.

Scientific data·2025
Same author

Experimental Observation of the Motion of Ions in a Resonantly Driven Plasma Wakefield Accelerator.

Physical review letters·2025
Same author

ROBIN: Reference observatory of basins for international hydrological climate change detection.

Scientific data·2025
Same author

Potential of accelerometer tags for monitoring of Japanese quail (<i>Coturnix japonica</i>) reproductive behaviour.

British poultry science·2024
Same author

Filamentation of a relativistic proton bunch in plasma.

Physical review. E·2024

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Background:

  • Multiple myeloma pathogenesis is increasingly linked to chromosomal abnormalities.
  • Specific genetic alterations correlate with patient prognosis in multiple myeloma.

Purpose of the Study:

  • To highlight the role of chromosomal abnormalities in multiple myeloma.
  • To emphasize the predictive value of cytogenetic findings for clinical outcomes.

Main Methods:

  • Review of current understanding of chromosomal abnormalities in multiple myeloma.
  • Analysis of the correlation between specific cytogenetic findings and patient outcomes.

Main Results:

  • Chromosomal abnormalities are significant factors in multiple myeloma development.
  • Detected genetic changes accurately predict patient clinical outcomes.

Conclusions:

  • Cytogenetic analysis is crucial for understanding multiple myeloma.
  • Integrating cytogenetic composition into patient evaluation is essential for future myeloma management.

Related Experiment Videos